Ampion is a treatment with much potential. It has already been reported to be effective in patients within a few hours and to have been still effective at the 12 week point (exactly 84 days) after injection. This suggests that it might need to be administered no more than about four (4) times a year. Hence the question arises: Might it be able to be administered less often, say twice a year? Would using a larger dosage facilitate that? Hence the FDA request to include a sample of patients receiving the higher dosage. AMPE appears to me to be quite undervalued.
ampiooooooh, once again you are deceiving this board with your short tactics. The chart in slide 11 clearly indicates that overall the PAIN LEVEL was much much lower compared to saline. Compared to patients that were injected with saline, Ampio showed a huge reduction in pain starting in day 8 and stayed low and almost constant all the way till day 84. Pain in patients that were injected with saline was skyrocketed starting in day 8. Now go look elsewhere for your pray.